1.Predictive Findings of Visual Outcome in Spectral Domain Optical Coherence Tomography after Ranibizumab Treatment in Age-related Macular Degeneration.
Yoon Hyung KWON ; Dong Kyu LEE ; Hyung Eun KIM ; Oh Woong KWON
Korean Journal of Ophthalmology 2014;28(5):386-392
PURPOSE: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). METHODS: We reviewed the medical records of patients with treatment-naive NV-AMD who underwent three or more consecutive anti-VEGF injections. The patients were divided into three groups according to their changes of visual acuity (VA); improved (group I), static (group S), or worsened (group W). We assessed the incidences and values of all available SD-OCT findings of these groups, compared these findings between the three groups and compared the initial values with the post-treatment values. RESULTS: Better initial VA and longer external limiting membrane (ELM) length were associated with less change in VA after anti-VEGF treatment. The initial VA was mildly correlated with initial photoreceptor inner and outer segment junction (IS/OS) length and initial ELM length. The final VA was also mildly correlated with the final IS/OS length and the final ELM length. VA was significantly changed after anti-VEGF treatment in groups W and I. With regard to incidence, disruption of the IS/OS (IS/OS-D), disruption of the ELM (ELM-D) and ELM length differed significantly between the three groups, particularly ELM-D. The incidences of IS/OS-D and ELM-D in group I were significantly lower than those in groups S and W, and those in group S were also lower than those in group W. The ELM length in group I was significantly longer than it was in groups S and W, and the ELM length in group S was longer than that for group W. However, these three findings did not change after the anti-VEGF treatment. CONCLUSIONS: Initial IS/OS-D, ELM length and particularly ELM-D can be useful predictors of the visual outcome after anti-VEGF treatment in NV-AMD patients.
Aged
;
Aged, 80 and over
;
Angiogenesis Inhibitors/*therapeutic use
;
Choroidal Neovascularization/*drug therapy/physiopathology
;
Female
;
Humans
;
Intravitreal Injections
;
Male
;
Middle Aged
;
Ranibizumab/*therapeutic use
;
Retinal Photoreceptor Cell Inner Segment/pathology
;
Retinal Photoreceptor Cell Outer Segment/pathology
;
Tomography, Optical Coherence
;
Vascular Endothelial Growth Factor A/antagonists & inhibitors
;
Visual Acuity/*physiology
;
Wet Macular Degeneration/*drug therapy/physiopathology
2.Therapeutic Thai of Recombinant Human Interferon-αA for a Case of Kaposi's Sarcoma.
Dae Won GOO ; Young Jin OH ; Hyung Ok KIM ; Jeung Kyu KIM ; Chung Won KIM
Annals of Dermatology 1989;1(1):28-32
No abstract available.
Asian Continental Ancestry Group*
;
Humans
;
Humans*
;
Sarcoma, Kaposi*
3.A Case of Progressive Zosteriform Macular Pigmented Lesion.
Oh Chan KWON ; Jong Kyu YANG ; Dou Hee YOON ; Tae Yoon KIM ; Hyung Ok KIM
Korean Journal of Dermatology 1998;36(3):456-459
Progressive zosteriform macular pigmented lesion(PZMPL) is a chronic pigmentary dermatosis similar to progressive cribriform and zosteriform hyperpigmentation(PCZH). This dermatosis described by Simoes in 1980 is characterized by a uniformly tanned macular pigmented lesion in a zosteriform distribution preceded by multiple pruritic macular pigmentation in a part of the dermatome for a period. PZMPL is not a fully understood disease entity but it is thought to be a variant of PCZH. It is differentiated from PCZH by accompanying pruritus as a prodromal symptom, a characteristic clinical course, and histological findings such as pigmentary incontinence. We report herein a case of PZMPL in a 17 year-old girl with the pigmentary skin lesion extending from the left forearm to the left chest along the Blaschkos line. The histological findings revealed increased melanin pigments in the basal layer and focal pigmentary incontinence in the upper dermis. To our knowledge, this case is the first report of PZMPL in korea thought to be the same case reported by Simoes.
Adolescent
;
Dermis
;
Female
;
Forearm
;
Humans
;
Korea
;
Melanins
;
Pigmentation
;
Prodromal Symptoms
;
Pruritus
;
Skin
;
Skin Diseases
;
Thorax
;
Triacetoneamine-N-Oxyl
4.Clinical Review of Tuberculous Meningitis in Children.
Hyung Kook KIM ; Mi Aie HAN ; Jong Wan KIM ; Chang Kyu OH ; Mahn Kyoo YANG
Journal of the Korean Pediatric Society 1988;31(7):892-900
No abstract available.
Child*
;
Humans
;
Tuberculosis, Meningeal*
5.Clinical Study on Torsades de Pointes.
In Taek OH ; Kyu Hyung RYU ; Kyung Pyo HONG ; Chong Yun RIM ; Young Bahk KOH ; Young LEE
Korean Circulation Journal 1989;19(4):716-725
Torsades de pointes is characterized by paroxysms of ventricular tachycardia at rates typically greater than 200 beats/min in which QRS morphology shows alternating polarity in an undulating pattern so that the complexes appear to be twisting about the beseline;this arrhythmia is virtually always associated with prolongation of the QT interval. Its importance lies not in its unusual structure but in the potentially fatal outcome if conventional treatment is administred. Torsades de pointes was diagnosed in 4 patients;the first with hypokalemia, the second with congenital QT prolongation syndrome, the third with amiodarone, the fourth with organophosphorous and hypokalemia. Treatment of these patients consisted of potassium supply, isoproterenol, lidocaine, phenobarbital, tenormin, phenytoin, cardioversion, atropine. Three patients improved successfully, but one patient died, as a direct result of the ensuing ventricular fibrillation and cardiac arrest on one hour after admission.
Amiodarone
;
Arrhythmias, Cardiac
;
Atenolol
;
Atropine
;
Electric Countershock
;
Fatal Outcome
;
Heart Arrest
;
Humans
;
Hypokalemia
;
Isoproterenol
;
Lidocaine
;
Phenobarbital
;
Phenytoin
;
Potassium
;
Tachycardia, Ventricular
;
Torsades de Pointes*
;
Ventricular Fibrillation
6.Early and Late Prognostic Factors of Acute Myocardial Infarction.
Kyu Hyung RYU ; Rho Won CHUN ; Dong Jin OH ; Kyung Pyo HONG ; Chong Yun LIM ; Young Bahk KOH ; Young LEE
Korean Circulation Journal 1991;21(2):218-228
We identified the early and late prognostic factors of acute myocardial infarction, and evaluated the clinical differences and the prognosis between Q-wave myocardial infarction and non-Q wave myocardial infarction. Total 146 patients who were managed from Jan 1987 to Aug. 1989 at hallym University hospital were evaluated. According to the presence or absence of Q wave on electrocardiogram, the patients were divided into two groups : a Q wave myocardial infarction group(QMI) and a non-Q wave myocardial infarction group (NQMI). Among 146 patients 109 patients(74.7%) had QMI and 37 patients(25.3%) had NQNI. The mean age, male to female ratio and serum cholesterol level were similar in both groups. But peak level of CPK was significantly higher in the QMI group than that in the NQMI group(P<0.01). Left ventricular end-systolic dimension and ratio of left ventricular dimension to wall thickness in the QMI group were significantly higher than that in the NQMI group(P<0.01). There were no significant differences between two groups in the incidences of mortality, postinfarction angina and re-infarction. During the in-hospital period female gender, old age(more than 60 years), Killip class at admission, early reinfarction and a history of hypertension were significant prognostic factors. main causes of death during the in-hospital period were ventricular tachyarrthymia, heart failure and cardiogenic shock. The incidences of mortality, heart failure and post-infarction angina during a mean follow-up period of 14 months (6~30months) were same in the two groups. The late prognostic factors were old age(more than 60 years), Killip class at admission, heart failure occured during follow-up period(P<0.001) and a history of diabetes mellitus(P<0.05). The patients with late postinfarction angina had more dilated left ventricular end-systolic demension(P<0.05) and lower fractional shortening(P<0.01) than those of patients without late postinfraction angina. There were no significant difference in long term survival rate between QMI group and NQMI group. Further prospective study should be performed to clarify the short and long term prognosis in patients with acute myocardial infarction treated by reperfusion.
Cause of Death
;
Cholesterol
;
Electrocardiography
;
Female
;
Follow-Up Studies
;
Heart Failure
;
Humans
;
Hypertension
;
Incidence
;
Male
;
Mortality
;
Myocardial Infarction*
;
Prognosis
;
Reperfusion
;
Shock, Cardiogenic
;
Survival Rate
7.Protection of Myocardial Ischemia during PTCA with the Autoperfusion Balloon Catheter.
Kyu Hyung RYU ; Dong Jin OH ; Kyung Pyo HONG ; Chong Yun LIM ; Young Bahk KOH ; Young LEE
Korean Circulation Journal 1992;22(4):547-556
BACKGROUND: An autopersion balloon catheter(ABC) was developed to allow passive myocardial perfusion during balloon inflation, through a central and multiple side hole in the shaft proximal and distal to the balloon. The ABC affords greater safety in performing PTCA of high risk stenosis involving the near ostium of the right coronary, the proximal left anterior descending(LAD) just proximal to the left circumflex artery and left main equivalent coronary arteries. METHODS AND RESULTS: In case 1, a seventy five percent right coronary ostial stenosis was reduced to less than 10 percent residual narrowing after PTCA with the ABC. In case 2, a seventy five percent proximal LAD(just proximal to left cirumflex artery) stenosis was reduced to less than 20 percent residual narrowing after PTCA with the ABC. In case 3, coronary angiogram demonstrated a 40 percent stenosis in the distal left main coronary artery as well as 80 percent stenosis in the proximal LAD.PTCA with the ABC was performed without significant hemodynamic compromise, achieving a less than 20 percent and 40 percent residual stenosis of the distal left main and proximal LAD respectively. CONCLUSIONS: 3 patients who would have required CABG had PTCA using the ABC.This ABC significatly reduces ischemic symptoms and signs during PTCA, allowing prolonged of balloon inflation.
Arteries
;
Catheters*
;
Constriction, Pathologic
;
Coronary Vessels
;
Hemodynamics
;
Humans
;
Inflation, Economic
;
Myocardial Ischemia*
;
Perfusion
8.Intermittent Parathyroid Hormone Treatment for Stimulation of Callus Formation on Distal Femoral Fracture in Elderly Patients: Case Report.
Won Taek OH ; Hyung Keun SONG ; Kyu Hyun YANG
Korean Journal of Bone Metabolism 2011;18(2):137-141
Fracture healing is the ongoing process but it is often delayed in elderly patients. Because the fractures in elderly patients with osteoporosis are severely comminuted and their quality of bone is poor, the associated delay of fracture healing is likely to lead to surgical failure. Recently, as a way to promote healing fractures, intermittent systemic parathyroid hormone treatment has been actively researched. Although the effect of parathyroid hormone, which is demonstrated by animal experiments, is well known, there are not many clinical applications. The authors report 2 cases which had the time-shortened callus formation by intermittent parathyroid hormone (teriparatide) administration after surgical treatment, maximum preservation of periosteum as possible, in elderly patients who have supracondylar fracture on distal femur.
Aged
;
Animal Experimentation
;
Bony Callus
;
Femoral Fractures
;
Femur
;
Fracture Healing
;
Humans
;
Osteoporosis
;
Parathyroid Hormone
;
Periosteum
9.The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema.
Yoon Hyung KWON ; Dong Kyu LEE ; Oh Woong KWON
Korean Journal of Ophthalmology 2014;28(5):379-385
PURPOSE: This pilot study aimed to evaluate the efficacy and safety of subthreshold micropulse yellow (577-nm) laser photocoagulation (SMYLP) in the treatment of diabetic macular edema (DME). METHODS: We reviewed 14 eyes of 12 patients with DME who underwent SMYLP with a 15% duty cycle at an energy level immediately below that of the test burn. The laser exposure time was 20 ms and the spot diameter was 100 microm. Laser pulses were administered in a confluent, repetitive manner with a 3 x 3 pattern mode. RESULTS: The mean follow-up time was 7.9 ± 1.6 months. The baseline-corrected visual acuity was 0.51 ± 0.42 logarithm of the minimum angle of resolution (logMAR), which was improved to 0.40 ± 0.35 logMAR (p = 0.025) at the final follow-up. The central macular thickness at baseline was 385.0 ± 111.0 microm; this value changed to 327.0 ± 87.7 microm (p = 0.055) at the final follow-up. CONCLUSIONS: SMYLP showed short-term efficacy in the treatment of DME and did not result in retinal damage. However, prospective, comparative studies are needed to better evaluate the efficacy and safety of this treatment.
Aged
;
Diabetic Retinopathy/diagnosis/physiopathology/*surgery
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Humans
;
*Laser Coagulation
;
Lasers, Semiconductor/*therapeutic use
;
Macular Edema/diagnosis/physiopathology/*surgery
;
Male
;
Middle Aged
;
Pilot Projects
;
Tomography, Optical Coherence
;
Treatment Outcome
;
Visual Acuity/physiology
10.The Comparative Hemodynamic Effects between Low Osmolar Ionic(Ioxaglate) and Non-ionic(Iopromide) Contrast Media during Left Ventriculography.
Cheol Hong KIM ; Kyu Hyung RYU ; Kwon Yeop LEE ; Dong Jin OH ; Kyung Pyo HONG ; Yung LEE
Korean Circulation Journal 1997;27(11):1169-1179
BACKGROUND: Various hemodynamic changes occur during left ventriculography, such as myocardial depression, hypotension, peripheral circulatory changes, ECG changes(such as arrhythmias and conduction abnormalities) and anaphylactic reaction etc. These effects are somewhat caused by osmolality, ionic concentration of Na+, viscosity and molecular weight of contrast dye and underlying various heart disease itself during left ventriculography. We compared the hemodynamic differences between ionic(ioxaglate) and non-ionic(iopromide) low osmolar contrast agents during routine ventriculography. METHODS: In a prospective, randomized, double blind study of 124 patients underwent left ventriculography, we examined the various hemodynamic effects of the two contrast agents on left ventricle. All subjects were divided into 2 groups : ioxaglate and iopromide groups. Also, each agent was used in randomized double blind fashion in both groups ; normal control subjects(14 in ioxaglate group : 12 in iopromide group) and subjects whose ejection fraction less than 50%(12 in ioxaglate group : 16 in iopromide group). Left ventricular systolic pressure(LVSP), left ventricular end-diastolic pressure(LVEDP), maximum dP/dt, (dP/dt)/P ratio, peak - dP/dt and Tau were obtained immediately before and left ventriculography. RESULTS: 1) In total(normal+angina+MI) subjects of both groups, LVEDP(p<0.001) and maximum dP/dt(p<0.001) were increased and T(au) was reduced significantly(p<0.05). But LVSP(p<0.001) and peak - dP/dt(p<0.005) were increased significantly only in ioxaglate group. 2)In normal(control) subjects, there were no significant differences in both groups, except LVEDP that was increased by equal magnitude(p<0.001). 3) In subjects with ejection fraction less than 50%, there were no significant hemodynamic differences in both contrast agent groups bur LVEDP increased significantly in both groups(p<0.001). CONCLUSIONS: This present study showed that both ionic(ioxaglate) and non-ionic(iopromide) low osmolar contrast agents were very safe without any significant side effects except two agents caused an increase in LVEDP and did not show major differences between ioxaglate and iopromide contrast agents from a hemodynamic point of view. Two contrast agents tend to improve contractilities and diastolic properties of left ventricle since both caused an increase in maximum dP/dt and a reduce in Tau, in total subjects. This effect may be caused by cardiac compensation, probably because of osmolality, volume loading by contrast agents and secondary activation of sympathetic system immediately after injection of contrast agents. Thus, it is concluded that two ioxaglate and iopromide contrast agents amy be used safely in left ventriculography in patients with and without left ventricular dysfunction, with paying attention to an increase in LVEDP.
Anaphylaxis
;
Arrhythmias, Cardiac
;
Compensation and Redress
;
Contrast Media*
;
Depression
;
Double-Blind Method
;
Electrocardiography
;
Heart Diseases
;
Heart Ventricles
;
Hemodynamics*
;
Humans
;
Hypotension
;
Ioxaglic Acid
;
Molecular Weight
;
Osmolar Concentration
;
Prospective Studies
;
Ventricular Dysfunction, Left
;
Viscosity